Brooks Laboratories Limited (NSE:BROOKS)
India · Delayed Price · Currency is INR 68.55
+3.26 (4.99%)
Jun 1, 2026, 3:24 PM IST
Brooks Laboratories Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 245.84 | -99.67 | -195.92 | -208.92 | -112.9 |
Depreciation & Amortization | 15.9 | 16.02 | 17.49 | 69.25 | 73.15 |
Other Amortization | - | - | 0.25 | 1.02 | 0.36 |
Loss (Gain) From Sale of Assets | -2.8 | -0.1 | - | -3.57 | -1.31 |
Loss (Gain) From Sale of Investments | -0.08 | 0.35 | -0.08 | -0.08 | - |
Loss (Gain) on Equity Investments | -187.79 | 129.84 | 211.21 | 33.1 | - |
Provision & Write-off of Bad Debts | 0.8 | -36.01 | -1.59 | 3.87 | 8.21 |
Other Operating Activities | 3.29 | 41.05 | 1.41 | -153.84 | -98.66 |
Change in Accounts Receivable | 38.22 | -32.21 | -33.83 | -26.87 | -50.06 |
Change in Inventory | -18.17 | 4.06 | 16.92 | 32.86 | -39.19 |
Change in Accounts Payable | -21.87 | -18.18 | -78.95 | 108.38 | -27.01 |
Change in Other Net Operating Assets | 19.6 | 21.1 | -34.91 | -0.1 | -127.01 |
Operating Cash Flow | 92.93 | 26.26 | -98.01 | -144.9 | -374.41 |
Operating Cash Flow Growth | 253.86% | - | - | - | - |
Capital Expenditures | -35.06 | -9.23 | -4.39 | -4.68 | -276.12 |
Sale of Property, Plant & Equipment | 2.8 | 0.1 | - | - | 29.1 |
Investment in Securities | 2.44 | -442.97 | 5.2 | 8.66 | -2.97 |
Other Investing Activities | 0.62 | 0.75 | 1.01 | 0.96 | 0.91 |
Investing Cash Flow | -29.2 | -451.35 | 1.82 | 4.95 | -249.09 |
Long-Term Debt Issued | 12.14 | 10.21 | - | - | - |
Total Debt Issued | 12.14 | 10.21 | - | - | - |
Long-Term Debt Repaid | -2.8 | -2.66 | -8.7 | -40.32 | -72.51 |
Net Debt Issued (Repaid) | 9.34 | 7.56 | -8.7 | -40.32 | -72.51 |
Issuance of Common Stock | - | 425.04 | 112.67 | - | - |
Other Financing Activities | -7.63 | -8.33 | -6.76 | 154.46 | 713.22 |
Financing Cash Flow | 1.71 | 424.27 | 97.21 | 114.14 | 640.71 |
Miscellaneous Cash Flow Adjustments | - | - | - | -0 | -0 |
Net Cash Flow | 65.45 | -0.82 | 1.02 | -25.82 | 17.21 |
Free Cash Flow | 57.88 | 17.04 | -102.4 | -149.58 | -650.53 |
Free Cash Flow Growth | 239.75% | - | - | - | - |
Free Cash Flow Margin | 6.66% | 2.06% | -12.88% | -23.67% | -71.34% |
Free Cash Flow Per Share | 1.97 | 0.64 | -4.00 | -6.05 | -26.33 |
Cash Interest Paid | - | 8.33 | 6.76 | 21.83 | 30.97 |
Cash Income Tax Paid | - | -5.06 | -1.99 | 1.53 | 2.63 |
Levered Free Cash Flow | 44.46 | -15.94 | -104.75 | 88.08 | -478.82 |
Unlevered Free Cash Flow | 49.68 | -10.62 | -100.22 | 100.29 | -461.12 |
Change in Working Capital | 17.78 | -25.22 | -130.77 | 114.27 | -243.27 |